Last reviewed · How we verify
Isodormid (apronal)
Isodormid (generic name: apronal) is a apronal drug. It is currently in unknown development.
Apronal is believed to work by modulating certain physiological processes, although the exact mechanism is unknown.
Apronal, also known as Isodormid, is a small molecule hypnotic/sedative drug of the ureide group, synthesized in 1926 by Hoffmann-La Roche. It is similar in structure and action to barbiturates, but is considered milder in comparison.
At a glance
| Generic name | apronal |
|---|---|
| Drug class | apronal |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Think of apronal like a key that unlocks a specific process in the body. When it binds to its target, it can either turn the process up or down, depending on what's needed. However, since we don't know what apronal's target is, we can't say exactly how it works or what it does.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Isodormid CI brief — competitive landscape report
- Isodormid updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Isodormid
What is Isodormid?
How does Isodormid work?
What is the generic name of Isodormid?
What drug class is Isodormid in?
What development phase is Isodormid in?
Related
- Drug class: All apronal drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing